Scott Epstein
@Avoro Capital Advisors Llc
Latest period2024 - Q3ReportedManaged Assets$6.858BTotal holdings36
Assets growth rate-8.66%Assets growth rate (2-Q avg)-10.54%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Avoro Capital Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.
Assets under management
The assets under management (AUM) of Avoro Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.858B in assets, with a quarterly growth rate of -8.66% and a 2-quarter average growth rate of -10.54%. The portfolio is managed by Scott Epstein, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
CERECerevel Therapeutics Hldng
| 0% | $308.292M 7.54M shares@ $40.9 avg price | Exited |
XBISpdr Series Trust - S&p Biotech
| 0% | $281.375M 3.035M shares@ $92.71 avg price | Exited |
ALNYAlnylam Pharmceuticals Inc.
| 0% | $97.2M 400,000 shares@ $243.0 avg price | Exited |
VRCAVerrica Pharmaceuticals Inc
| 0% | $29.16M 4M shares@ $7.3 avg price | Exited |
BCYCBicycle Therapeutics Plc
| 0% | $14.168M 700,000 shares@ $20.24 avg price | Exited |
ADVMAdverum Biotechnologies Inc
| 0% | $2.858M 416,666 shares@ $6.87 avg price | Exited |